Sherlock Biosciences
CRISPR diagnostics company licensed from Broad Institute — SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) for multiplexed rapid nucleic acid detection.
- Country
- United States
- Revenue
- ~$10M
- Employees
- ~60 emp
ISO 13485
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| CRISPR diagnostics | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.